"Carl Icahn - one of Wall Street's most renowned and successful investors - is on another mission; this pitbull is sinking his teeth into one of the companies in our portfolio - Enzon Pharmaceuticals (NASDAQ: ENZN)," notes Marc Lichtenfeld.

In Xcelerated Profits Report, the senior analyst and noted healthcare sector expert takes a look at the small cap biotechnology, which is involved in developing products for the treatment of cancer.

"With an infamous reputation for diving into stocks that he perceives as undervalued and shaking up management teams in order to boost shareholder value, Icahn us one of the best 'business partners' we could have.

"One of the big reasons why we recommended Enzon was because some major institutional investors are clamoring for change at the company. They contend that if Enzon was better at maximizing its true potential, the stock could easily vault from its current undervalued state and generate some real wealth for its shareholders.

For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.

"My more speculative idea for 2008 is Immersion (NASDAQ: IMMR)," says Karim Rahemtulla, investment director for Xcelerated Profits Report.

"This time last year, Immersion shares were trading in the single-digits. But when the company finally prevailed in its prolonged patent infringement lawsuit against Sony, the stock took off.

"The company is an industry leader in the field of 'haptics' and touch-sense technology. This is the kind of software you find in PlayStation gaming consoles and associated games – which makes the controller vibrate and puts gamers into the action more realistically.

"But the company also has major revenue streams in a variety of areas. In the medical industry, for example, its force-feedback technology is helping surgeons train in a more realistic way, replicating the motion in the human body. The medical segment is Immersion's biggest revenue generator, accounting for around 40% of annual revenues.